Nootropic Focus

The Nootropic Focus stack combines two Russian-developed neuropeptides that operate through complementary mechanisms to enhance cognitive performance while reducing anxiety. Semax is a synthetic analog of ACTH(4-10) — the fragment of adrenocorticotropic hormone responsible for its cognitive effects without the adrenal-stimulating properties. Semax increases brain-derived neurotrophic factor (BDNF) expression by 3-4x in the hippocampus and prefrontal cortex, promotes nerve growth factor (NGF) synthesis, and modulates dopaminergic and serotonergic neurotransmission. In Russian clinical use since 1994, it is prescribed for cognitive impairment, stroke recovery, and optic nerve atrophy. Selank is a synthetic analog of the naturally occurring immunomodulatory peptide tuftsin, with an additional Pro-Gly-Pro sequence that increases its stability and CNS penetration. Selank''s primary mechanism involves modulation of the GABAergic system — it acts as an anxiolytic without the sedation, cognitive impairment, or addiction potential of benzodiazepines. It also influences the expression of BDNF and enkephalins, creating a calm-but-focused mental state rather than the wired alertness of stimulants. The synergy between Semax and Selank is particularly elegant for cognitive enhancement: Semax provides the "drive" component — increased BDNF, enhanced dopaminergic tone, improved attention and working memory — while Selank provides the "calm" component — reduced anxiety, stabilized mood, and prevention of the stress response that impairs prefrontal function. Together they create a state of relaxed concentration ideal for demanding cognitive work. Both are administered nasally for direct access to the CNS via the olfactory epithelium, bypassing the blood-brain barrier. The nasal route provides onset within 5-15 minutes and duration of 4-6 hours.